Global Engage presented 'The Discovery & Development Summit Asia 2025' a premier breakthrough event in Singapore on ...
Researchers at the Antimicrobial Resistance (AMR) interdisciplinary research group of the Singapore-MIT A...
Soft tissue deformation during body movement has long posed a challenge to achieving optimal garment fit and comfort, pa...
Targeted protein degraders (TPD) are rapidly moving from niche science to mainstream drug development, with few therapie...
Developing effective antiviral drugs against mosquito-borne viruses like dengue and Zika requires understanding the func...
Australia's University of Queensland (UQ) researchers have been the first in the world to successfully grow fully functi...
The Asia Bio Innovation Summit 2025, held in Singapore, emerged as a landmark event in the biopharmaceutical industry, f...
US-based startup Skyhawk Therapeutics, Inc., a leader in the discovery and development of small molecules that modulate ...
GC Biopharma, a South Korean biopharmaceutical company, has signed a Memorandum of Understanding (MoU) with the Thai Red...
Singapore's 65LAB has awarded US$1.5 million (approx. S$1.9 million) to Professor Enrico Petretto to advance a breakthro...
In celebration of the World Hepatitis Day (28 July), HCSA Community Services and Tan Tock Seng Hospital (TTSH), an ancho...
Life Biosciences, a US-based biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent mul...
Alloy Therapeutics Co. has announced the signing of a Memorandum of Understanding (MoU) with the Kansai Startup Academia...
The Global Antibiotic Research & Development Partnership (GARDP) and Institute of Science Tokyo, in Japan, have sign...
365mc, South Korea's leading medical institution specialising in fat reduction treatments, and Israel-based Ra...
South Korea-based startup Illimis Therapeutics has announced the closing of 58 billion KRW ($42 million) Series B financ...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
RDP Pharma AG, a Swiss biotechnology company focused on next-generation protein degradation therapeutics, and the Experi...
